Ma, K.S.-K.; Lee, C.-C.; Liu, K.-J.; Wei, J.C.-C.; Lee, Y.-T.; Wang, L.-T.
Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials. Pathogens 2021, 10, 1537.
https://doi.org/10.3390/pathogens10121537
AMA Style
Ma KS-K, Lee C-C, Liu K-J, Wei JC-C, Lee Y-T, Wang L-T.
Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials. Pathogens. 2021; 10(12):1537.
https://doi.org/10.3390/pathogens10121537
Chicago/Turabian Style
Ma, Kevin Sheng-Kai, Chien-Chang Lee, Ko-Jiunn Liu, James Cheng-Chung Wei, Yuan-Ti Lee, and Li-Tzu Wang.
2021. "Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials" Pathogens 10, no. 12: 1537.
https://doi.org/10.3390/pathogens10121537
APA Style
Ma, K. S.-K., Lee, C.-C., Liu, K.-J., Wei, J. C.-C., Lee, Y.-T., & Wang, L.-T.
(2021). Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials. Pathogens, 10(12), 1537.
https://doi.org/10.3390/pathogens10121537